Richard A. Baron's most recent trade in Immunome Inc was a trade of 6,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 8, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Richard A. Baron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Richard A. Baron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 6,500 | 6,500 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Richard A. Baron | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.38 per share. | 18 Aug 2021 | 2,343 | 2,343 | - | 11.4 | 26,663 | Common Stock |
| Immunome Inc | Richard A. Baron | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2021 | 2,343 | 5,157 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Richard A. Baron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Richard A. Baron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2020 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) |